In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

The new ESC Guidelines on myocardial revascularisation: percutaneous or surgery for my patients?

ESC webinar

Add to calendar25/09/20140:00 25/09/20140:00 Europe/Paris The new ESC Guidelines on myocardial revascularisation: percutaneous or surgery for my patients? European Society of Cardiology contact@escardio.org DD/MM/YYYY
Chronic Ischaemic Heart Disease (IHD)
Cardiovascular Surgery


Get the essential information in order to optimise your daily practice of personalised-medicine.

Share a practical method of reasoning that helps you to develop an answer to the question: What is the best myocardial revascularisation strategy for each patient presenting with multivessel coronary artery disease, considering his/her clinical status, and in the light of best available evidence and clinical experience?

Stephan Windecker and Jean Marco

ESC/EACTS Guidelines in Myocardial Revascularisation

 

 

The ESC Webinars are designed to help you improve your daily practice!
The format includes the presentation of 2 clinical cases and live discussions with the 2 key opinion leaders who will give you some useful tips for your daily clinical practice.

This programme is supported by Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb and Pfizer Alliance, Daiichi Sankyo Europe GmbH, Novartis Pharma AG and SERVIER in the form of unrestricted educational grants.
The scientific programme has not been influenced in any way by its sponsors. Read more about the ESC Consolidated Educational programme sponsorship here

Russian subtitles